Tag Archives: Timo Ahopelto

Ductor 1.1: Business as usual
(=no business)

Since my last piece about Ductor Corporation (registered also as Ductor Oy, Ductor Ab, Ductor AG, Ductor Ltd and other names) the company made several strange moves. Known in the finnish business press as an enterprise “to invest in, if you want to lose your money with near certainty“, it informed about a new investment round of 2 million Euro.

While that it is hardly new for an enterprise which took in “stupid money” investments of over 30 million Euro to develop a crackpot’s idea into a working product (offended by my wording? read Vol. 1), this time the first public announcement came after the round closed. But they nevertheless tried to make it look like a “successful public round”.

When I wrote about Ductor in July 2020, the round wasn’t there on Springvest’s website. This was also witnessed by the usual investor blogs, which told about the rounds before and after (Medixine and Multitaction), but not Ductor’s. Furthermore, the company claims the round had been active for 5 days only. Normally, these rounds last several weeks.

We can update our information to 2020 with the numbers Ductor released now.
Investments to date: 32,6 million (30,6M+2M); 2/3 from small shareholders.

Ductor is again predicting enormous revenue for the ongoing fiscal year and beyond, but this time, a new red banner appeared which warns explicitly that these numbers are as much phantasy as they are phantastic. This banner hasn’t been there before my July blog posting, where I criticized this practice.

This may well be a coincidence, as well as this whole mysterious “retrospective” investment round. But there is yet another coincidence, that appeared after I blogged about this enterprise.

Ductor Corp. has “updated” their 2019 balance twice since then. One of the updates – and that is quite unusual – contained an English translation of the auditor’s report.

This doesn’t counter a single character of my criticism, as it says straight that the balance is prepared under Finland’s accounting law, which is different from the rules in the countries where Ductor has moved its risks.

Adding to the bizarre story, this statement was audited and signed by Ernst & Young (now EY), which has been since under fire for providing the world with the worst (but most entertaining) auditing scandal in Europe’s modern history. The affirmation of correctness underwritten by an auditor, who can be duped by faked screenshots of bank accounts to sign off multi-billion frauds, counts … virtually nothing.

 

HumanCharger-Valkee leaving the stage

Finnish media reported last week, that Valkee Ltd. is now registered on the public list of insolvent debitors (protestilista). The maker of the HumanCharger scam devices, which has received stupid money investments of more than 10 million Euro and is chaired by the “famous” Timo Ahopelto, is now unable to pay bills as low as €1000.

The press reports show, that despite being otherwise a small and rather unimportant company, Valkee is still of interest because of the vast media attention it received in the past. This development was furthered, predicted and documented by this blog for years.

The snail media, having re-published my stories repeatedly without revealing the source, missed a certain detail. Valkee Ltd has also been forced out of their long-term headquarters in Oulu. Their website still speaks about “R&D and production facilities [which] are located adjacent to the company’s headquarters in Oulu, Finland”. In fact, Valkee could no longer pay the rent in Elektroniikkatie 3-5. The new address is in Lummintie 11 in Oulunsalo.

There is not much space for production and R&D, adjacent to a massage therapist.

The company is so desperate, it sells the devices now for $87 (previously $219). In Europe these are out of stock, no cash to manufacture any more. This is how the story ends.

Ductor, Vol. 1: Let There Be Gas

In the last weeks, there has been considerable interest in my blog post from May 2016, where I wrote about strange investments by LifeLine Ventures, managed by controversial investor Timo Ahopelto.

Of these, Valkee is the most notorious here in Finland. Its product, the earlight device which is now called HumanCharger, has become a popular synonym for “scam”. Valkee is technically bankrupt since 2017, has lost it’s last international investors, and was just a few days ago again noted in the press for being listed in the public register of insolvent debtors. Led by Ahopelto for more than 10 years, it is expected to leave the stage soon, but not before adding another 200 indiegogo crowdfunders to the number of 100.000 defrauded customers, who wasted around €200 each for a quack treatment.

uBiome, another declared favorite of Ahopelto and LifeLineVentures’ flagship investment, made devastating headlines in the US. After the FBI raided their headquarters, it turned out the founders – which Ahopelto held in especially high regard – had lied about nearly anything; one even about her age. uBiome filed for bankruptcy shortly thereafter, and their assets were auctioned – netting in about 1% from their earlier valuation of $600M.

The story of the third company I listed back then, Ductor Oy, is at least as bizarre as these earlier cases. However, it went mainly unnoticed so far. I try to line out its history, business and financing practices in the first part, followed later by another piece about their “revolutionary product”. Opinions, threats and the usual insults shall be put in the comments section or directed at earlightswindle@gmail.com.

>corrections after publication marked & at the end of the text<

May I have your full attention now, it is absolutely worth it. All details below, as unbelievable they might feel, are taken from the company’s own material and statements of the people involved. All is linked directly to sources. If there’s any speculation from my side, it’s noted in the text. Here we go.

 

Founded by “Jesus”

Ductor was founded in 2009 on orders from God. This can be directly inferred from the circumstances described on the Facebook page of Veikko Latvala. Ductor’s co-founder calls himself a “healer and seer”, who can cure “migraine, back pain and cancers”.

 

2008 and 2009 saw the publication of two books dictated by God into Veikko’s pen. God dictated even the colour of the book cover, according to Latvala. (The full translation is available here as PDF.) In the end, Ductor’s co-founder even hints he might be a reincarnation of Jesus, because a “Holy Man” is sent to earth every 2000 years.

While God was still dictating the second book (to becompleted in spring 2009), the farmer Latvala founded Ductor together with Ari Ketola. Ketola has changed his name to Ari Mokko in 2020. The company entered the finnish trade register in February 2009 (no. 2009/613158).

 

Latvala was Ductor’s chairman from 2009 until 2012, when he handed the position over to the CEO Ari Ketola, a faithful follower of the prophet. Latvala then assumed the role of Ductor’s director until June 2019. Ductor’s investor material from 2017 (PDF) says, that Latvala was responsible for R&D and product strategy.

According to archived versions of Ductor’s website, Veikko Latvala is an “inventor” and “the original founder of the Ductor idea”. He resigned from the board last year (Latvala turns 80 in 2020) but remains the second-largest shareholder.

The third director has been Timo Ahopelto since 2012, the year LifeLine Ventures started to invest in Ductor. Neither Ketola, Latvala nor Ahopelto have an appropriate scientific or somehow professional background. Latvala was a farmer, Ahopelto helds a Master in industrial management, and the CEO Ketola has only had vocational training as a “merkonomi“, the finnish basic requirement for salesmen. The finnish press picked up these strange directors’ background once in 2016.

 

A sticky vision

The company was probably financed during its early years mainly by Ketola, who had made a small fortune by introducing the ESPRIT clothing brand onto the finnish market.

Ductor today tells about its beginnings (source: Ductor material 2019, p.20), that Latvala and Ketola “analyzed” the problems of the world’s food production and wanted to find biological methods to ensure the planet would cope with population growth. Ketola than organized a “challenge” to scientists at the University of Helsinki, prompting them to find a method which employs microorganisms to produce ammonia – while removing nitrogen from agricultural waste.

I cannot really imagine a situation, where an outsider – especially a textile salesman fulfilling a vision of a farmer-prophet – contacts a leading university’s scientists, “hey we need some fitting science for this idea we had”. Accordingly, the first patents filed for Ductor list only Latvala and Ketola as “inventors”. Only later applications then have names of actual researchers, too.

The prophet’s idea, without a working process, however, was enough to ensure excessive funding in 2012 by TEKES (now part of BusinessFinland) and, as noted before, by Ahopelto’s LifeLine Ventures. This was probably made possible by the first patent application for the “Ductor technology”, filed by Latvala and Ketola in June 2012.

Ductor was awarded instantly a staggering 1,145 million Euro by TEKES, and received an undisclosed sum from LifeLine Ventures. During the following years, public funding granted would rise to a total of 3,7 Million.

1,4 million were granted in 2014 and 2016, when Ahopelto was on the board of TEKES. Here’s the same problematic pattern we’ve seen before with Valkee and other companies.

Despite their involvement with Ductor, its founders made appearances as prophet and apostle – that’s my interpretation of Ketola’s statements. Veikko Latvala was repeatedly cited in the yellow press for his prophecies, in which he predicted, for instance, the end of Finland’s governing coalition in 2014, and the end of the European Union for 2017.

To be fair, he’s widely regarded as a crackpot, although some still adhere to Latvala’s teachings: There is a whole website with his forecasts,of a disciple[*] which published the final message on May 31 2020. It commented on the Coronavirus pandemic and said “you will hear from me again”.

 

Cash flows

Ductor’s main business in terms of generating cash flow have been ever repeated investment rounds. Until June 2019, it’s been over 21 million through direct issuing of shares, crowdfunding, convertible bonds, and other instruments.

 

Several rounds were organized by kansalaisrahoitus.fi (now turned into Springvest). The last offerings I’m aware of have been convertible bonds, partially through a finnish variant of “crowdfunding” in February 2019 ((planned 2,25 million Euro) and June 2019 (3,6 million).

 

Promises and Lies

All investor prospectus material issued for the public rounds reiterates these points:

  • the multi-billion market for Ductor’s biogas solutions
  • the multi-million revenue predicted for the coming fiscal year
  • the technological progress and the growing customer base.

The latter will be X-rayed in my second post. The billion euro potential is something that many startups include in their investor attraction marketing. The exorbitant revenue predictions for the next fiscal year are a Ductor specialty, given that Ductor has made no revenue at all to date.

As an example, here is Ductor’s forecast as of December 2017 from the 2017 prospectus. Projected revenue in orange, the real result until 2019 is marked in dark blue.

In early 2019, the revenue for the already completed fiscal year 2018 was said to be €1,3 million, and for the ongoing 2019 a 75 million jackpot was expected.

 

In the balance for 2018, which was published in July 2019, the 1,3 million had shrunk to €14.000. The prognosis for 2019 was quite volatile through the fiscal year, it was given as 40,8 million in June (down from the 75 million in February).

 

The published balance for 2019 showed €726.000 instead – another 40 million evaporated in half a year. A closer look even reveals, that of this meager result only €17.700 were from sales to other entities than their own group.

To repeat the joke from above: Actual revenue is marked in neon pink.

 

In my understanding, forecasts for the ongoing fiscal year should be somewhat more reliable. Here, investors are recruited with a promise for the upcoming months. This is clearly something else as the extraordinary prognoses for the years to come.

While this may still be somehow in a grey zone, Ductor has also lied directly in more than one prospectus. It’s about the formula which is in all material: In the last 5 years, none of the board members or other leading management

has held a leading position, such as a member of the administrative, management or supervisory body, or has been a member of the management body as such in a company that has filed for bankruptcy, liquidation or reorganization

Timo Ahopelto was chairman of at least one company that filed for bankruptcy in 2018. Optomeditech Oy folded in November of that year, with Ahopelto being chairman since 2013, according to the finnish trade register (no. 2018/531107).

I did not check systematically if there are more cases, since the worst (like uBiome) are not on LifeLine Ventures investments page. Such false information can lead to legal action and liability claims.

Ductor had hinted at a possible IPO in 2020, but this did not go further. It would have led to more scrutiny, which inevitably had uncovered such weak points. Instead, Ketola/Mokko has told that a “partial exit” is planned for this year. Hard luck for the new owner.

 

Where’s the money?

Finnish companies are allowed to include all kind of acronyms into their name, also such that resemble those of foreign business entities. A firm could those be called a PLC, Ltd, LLC, Inc., GmbH, AG, or whatever, without being incorporated in the respective countries as such. This is helpful, when a company needs to assume or deny identity to conceal creative accounting or unclear transactions.

Ductor has pulled such a trick by registering in Finland concurrently as “Ductor AG”, like the german and swiss Aktiengesellschaft. According to the swiss trade register (SHAB), it founded a company with the same name in Zug am See in 2018. Since then, it’s called a “swiss-finnish company”. In Ductor’s balances since then, there are assets of several million Euro allocated to Ductor AG and the german subsidiary Ductor GmbH, and other such companies in the rest of the world.

The AG has not filed a balance yet, but the GmbH has done it up to 2018. The german branch has had a debt of 1,4 million Euro, of which 437.000 were not covered by other assets. In other words, Ductor’s balance is in fact not “balanced” as required, when we assume that the GmbH’s debt is to Ductor in Finland, as the finnish papers suggest.

It’s not clear what else is behind this construct, and it’s nearly impossible to get a complete picture from outside of the company. An auditor would need access to internal documents from all continents, which seems unrealistic.

With all that money, it may be possible to make progress and even develop revolutionary methods and products as envisioned by Latvala and Ketola ten years ago. The real outcome of this mayhem, however, will be the subject of my second Ductor post.

In my opinion, one thing can be taken for granted already: Even if Ductor would make profit in a distant future, the finnish tax payer and the crowdfunder-investors won’t get their share. Ductor is prepared.

 

[*correction 8.8.2020: the website in question is influenced by his teachings, but the maintaining person says the prophecies are her own; Latvala made her see these]

HumanCharger: Indiegogo campaign fails, last investor pulls out (update)

Valkee (alias HumanCharger) has had a single foreign investor since 2013: Merieux Developpement, which financed the earlight company together with Lifeline Ventures and the finnish tax payer. As the co-lead investor, Merieux Dev. had its partner Valerie Calenda on Valkee’s board. Until now.

 

According to the trade register, Calenda has resigned from the board recently. Merieux Equity Partners, which holds the active investments of Merieux Dev., no longer lists Valkee on its portfolio pages. From the french investor’s “regional partners” category disappeared Seppo Mäkinen, former Sitra director, and probably the person who lured Merieux Dev. into this adventure.

 

There is no explanation other than Merieux has backed off and written down its multi-million loss. Now Valkee’s HumanCharger operations are completely controlled by its own folks: the CEO Aki Backman, the inventor Juuso Nissilä, and Timo Ahopelto.

The struggling company had high expectations for their follow-up product to the old LED headset: The HumanCharger Wireless Headset, an ugly and hard-to-wear bluetooth device. It launched an Indiegogo campaign, which looks like a complete desaster already.

 

Featured prominently at reddit/shittykickstarters, people aren’t buying it for half the price.

One backer has left a positive comment, looks like here’s really an impressed user.

 

It’s Timo Ahopelto, the company’s chairman, who felt the urgent need to push his product. Probably it won’t help.

***

UPDATE 7.12.2019:
Valkee’s “HumanCharger” managed to reach 55% of the 30.000€ funding goal on Indiegogo after a month. They added another month and got 40% more, still unable to reach their low aim. They crossed the 100% with the help of two “backers” who sponsored the company with >2000€, not claiming a perk. Probably, these were staffers.

To “reach” the goal made it possible to sell the scam devices still over IGG under the “onDemand” label. The demand is 2-3 devices per week.

These facts are recorded on IGG trackers, like backerkit.com.

Valkee Humancharger shutdown – temporary or final?

This blog – as the previous earlightswindle.com – was once reporting exclusively about the multifaceted scamming activities of finnish company Valkee Ltd, maker of the fake “light therapy device” HumanCharger.

Now it seems they are finally phasing out of business. The company is technically bankrupt since March 2017, but now

The finnish trade register says, that in May 2018 the main shareholders LifeLine Ventures, Vera and Merieux forgave the company another 230.000€ convertible loan; i.e. was converted into worthless shares. The same happened to several other such loans during the last two years, rising the amount of burnt money to more than 10 million Euro.

The next months will now be decisive. I am looking forward and will inform as always.

Finnish “innovation agency” leader: Evolution is a question of belief

…those are the oldest brain areas, if you believe that the brain has developed evolutionary, in a way […] depending to who you listen to

This (and other stunning announcements) is from an interview* by Timo Ahopelto, a lead strategist5006-512 at Finland’s tax-financed innovation funding agency TEKES. Many of his companies received TEKES funding5006-512 – including the ill-fated Valkee Ltd5006-512.

Ahopelto has made antivax statements5006-512 and often uses crude war- and propaganda rhetoric5006-512, especially against critics. Another incredible demonstration of what – or who – is possible in Finland, with the right connections and political support.

*at 27:55 in the SmartDrugsSmart podcast, MP3 download here 5006-512.

Suomeksi:

nuo ovat aivojen vanhimmat osat, jos uskot että aivot kehittyivät evolutionäärisesti, [se tavallaan] riippuu siitä, keneltä kysyt

Valkee Ltd collapses as predicted: All share capital lost

UPDATE: My original story has reached more than 500.000 800.000 readers.
See ILTALEHTI | KAUPPALEHTI | TEKNIIKKA&TALOUS | ILTA-SANOMAT etc.pp.

The finnish trade register has just announced, that the HumanCharger manufacturer Valkee Ltd has lost all of its share capital. That means, that all of the company’s ressources are depleted, and new capital is not in sight – not even theoretically.

valkee-bankrupt

In other countries, the firm would have to file for immediate insolvency or bankruptcy, which is regulated in the same chapter of finnish corporate law.  In Finland, however, business could go on for a while – under extreme conditions, as purchases must all be paid in advance, and credits are stroke off. All business partners are now informed officially, that Valkee cannot fulfil upcoming liabilities.

Because of the consequences, such a notification is usually done in the least possible moment. It may be driven by the fact, that management and owners can be held liable personally from now on, if they don’t declare the final state publicly.

If anyone has claims against Valkee Ltd, now is the time to demand.

Personally I think, that the company will exist on paper for a few months, until its chairman Timo Ahopelto resigns from the board of TEKES, Finland’s tax-financed innovation funding agency. TEKES has shot in more than 100.000€ last year into Valkee, despite the obviously desperate state of the company, which was strictly documented in the 2016 balance.

Probably it’s the political dimension of the case. The snail media will report more soon. The source is earlightswindle.com – just in case they “forget” it again. /-Ed.

Valkee ist pleite

Wie die finnische Registerbehörde PRH gestern mitteilte, hat der Ohrleuchtenhersteller Valkee Oy aus Oulu am vergangenen Donnerstag den Verlust des gesamten Stammkapitals gemeldet.

valkee-bankrupt

Während nach deutschem Recht die Gesellschafter zum sofortigen Insolvenzantrag verpflichtet wären, kann die Firma in Finnland unter Umständen fortgesetzt werden. Wegen der Auswirkungen auf die Geschäftstätigkeit (Einkäufe nur noch gegen Vorkasse, Kündigung von Kreditlinien, usw.) ist aber eine Insolvenz mit Gläubigerschutz und Sanierungsversuch oder ein direkter Konkurs wahrscheinlicher. [s. Abschnitt 20, §§23-25 des finnischen Kapitalgesellschaftsgesetzes: Stammkapitalverlust, Insolvenz und Konkurs]

Die Meldung über den Stammkapitalsverlust erfolgt in der Regel zum allerletzten rechtlich möglichen Zeitpunkt. Unterbleibt die Anzeige, oder erfolgt sie zu spät, können Geschäftsführung und Gesellschafter im Falle des Konkurses in Anspruch genommen werden. Hiermit zeigen demnach die Verantwortlichen bei Valkee an, dass sämtliche finanziellen Möglichkeiten ausgeschöpft sind, und sie nicht persönlich haften wollen.

Da das Schicksal von Valkee in Finnland wegen der Verwicklung der Regierung politische Bedeutung hat, könnte die Skandalfirma auf dem Papier noch fortbestehen – etwa bis zum Sommer 2017, wenn der Firmenchef Timo Ahopelto vom Leitungsgremium der Innovationsförderungsbehörde TEKES zurücktritt. TEKES hat im letzten Jahr noch über 100.000 € in Valkee nachgeschossen, obwohl die Geschäftsführung öffentlich zugegeben hat, dass die Ohrleuchtengeräte in Finnland unverkäuflich sind und der sinkende Auslandsumsatz maximal 1/4 der Kosten deckt.

Wenn Sie noch Ansprüche an die Firma Valkee haben, dann ist jetzt der Zeitpunkt, sie anzumelden. Das Zeitfenster kann sich bald schließen.

Don’t use HumanCharger for Seasonal Affective Disorder: Valkee fools the FDA

As reported earlier on earlightswindle.com, the U.S. Food and Drug Administration has refused the import of Valkee’s HumanCharger earlight headset into the States, when it was misbranded as a therapy device. But now Valkee Ltd actually did a rererere-launch of their hokuspokus in Canada and the US. How is this possible?

Valkee’s resellers explain on amazon.com, how Valkee circumvents FDA requirements.
Hold on to your seats!

“Doesn’t this need FDA approval?”

valkee-fuck-fda

“Only if advertised for use in Seasonal Affective Disorder. The product is advertised for Winter Blues”

It can not make any effectiveness claims, it gets no FDA approval – but it works “for winter blues”? That’s a synonym.

The USA is a known minefield for health fraud businesses like Valkee’s, because of class action suits. Power Balance, the magnetic wrist band sellers, had to return most of their shady businesses’ profits, because they made false health claims.

Valkee really doesn’t know better than to fool around with U.S. legislation. On the other hand, there is nothing to regain from Valkee, as the Company has no assets. They didn’t make even profits.

Congratulations to Merieux Developpement, TEKES and SITRA for making these shameful maneuvres possible. This is what sustainable businesses look like (in Finland)!

Finnish pension millions invested in questionable companies: Valkee, uBiome, Ductor &Co.

The earlight maker Valkee Ltd has caused much anger here in Finland for wasting millions of tax money. The money was channeled through TEKES, the “Finnish Funding Agency for Innovation“. The number is usually named as ca. 2,5 million Euro. But that’s only the beginning.

The main “private” investor in Valkee, as opposed to the public, was LifeLine Ventures, by its founding partners Timo Ahopelto and Petteri Koponen. Millions of its funds went into the earlight. TEKES has given an extra 3 million € for the first fund in question. A considerable portion of that has to be added to public funds wasted for the scam.

from the TEKES website: its "best funds"

from the TEKES website: its “best funds”

Additionally, the LifeLine funds got millions from Mutual Pension Insurance Ilmarinen, the biggest pension insurance company in Finland with over 500.000 insured. Starting with nearly a million € in 2012, when the LifeLine fund was opened, its stake has risen to nearly 4 M€ in Ilmarinen’s 2015 balance (PDF, p. 102).

from Ilmarinen's 2015 balance

from Ilmarinen’s 2015 balance

In Finland, one pays pension insurance directly from the pay check, every month. At the moment, it’s 5,7% for workers under 53 years, and 7,2% for the older. So Valkee has not only burned tax money, but also pension funds.

valkeestreamofmoney

There’s good reason to look, what other companies LifeLine has invested in. Besides taxes, who would give pension funds for questionable activities?

Hopefully, the following list is not representative.

 

Ductor

Ductor Ltd promises to help solving the world’s energy problems by making available up to 100% of chicken poop for biogas production (short description). It is marketing itself even as the new Nokia. Not making this up!

Its Board of Directors has caused considerable irritation. It consists of three persons:

  1. Ductor’s CEO and founder Ari Ketola, a former textile trader;
  2. the “prophet of GodVeikko Latvala;
  3. Timo Ahopelto from LifeLine Ventures.

They present the ownership: Ketola 50%, Latvala 33%, LifeLine 16% (numbers from 2015).

The Book of Veikko. - Jesus!!

The Book of Veikko. – Jesus!!

Ketola is a follower of the “Prophet” Latvala, he praises him as his mentor, having “this gift of mercy last twenty years”(sic!). Latvala briefly became known in the western world, thx to Fox News, for claims he’d cracked the code of the world-famous Voynich manuscript with the help of God. It turned out to be bogus, as prophecies usually do. He said the EU would end in 2014, but to my knowledge, it’s still around. (Btw, is it?)

Maybe found in Voynich's

Bacteria from Voynich’s?

The business idea came from a tête-à-tête with his prophet, Ketola says. The right bacteria needed for the process was found straight away, when Ductor started. He doesn’t tell if God helped with that, also. An ex-manager, who left Ductor in 2015, described the company leaders as completely incompetent. That would fit.

So far, Ductor has made millions of loss and 4 contracts in Germany. It is unknown whether their plant add-ons will work in real world settings.

Update Feb 2017: The opening of the first german plant was delayed twice, and mentions have disappeared from Ductor’s website.

May a little prayer help? – More soon…

 

uBiome

Another LifeLine investment concerned with feces is uBiome “from the Valley”, as Ahopelto calls it. It sells test kits in which you can fill in poop (for $89) or swab mouth and private parts (for $399). The samples are then screened for the different bacteria they contain. There isn’t much to learn from this for the user, the results are meaningless – unless, one day, somebody finds out.

Apologies for this one.

Apologies for this one.

In a cool twist, uBiome promises to be that somebody. If just enough people buy their test kits – and/or enough money is thrown at them – there may be results to tackle mankind’s worst killers.

For example, with 500 people, uBiome will be able to answer questions about (…) diabetes and hypertension. With 2,500, the project can investigate connections to breast cancer. With 50,000 people, the project can begin to address multiple sclerosis and leukemia

Promising too much, at the very least. Some may smell a scam herein. uBiome calls their efforts “citizen science” and has defended its lack of institutional (scientific/ethics) control, blaming the science community as old-fashioned, building obstacles for projects like theirs.

These are basically the same conspiracy theories, which Ahopelto used to defend Valkee Ltd.

 

ZenRobotics

ZenRobotics makes AI-powered robots sorting waste. I’m naming it, because it’s been one of Ahopelto’s favorites for years. Unfortunately, it made more than 13 million € loss so far, i.e. all invested money. Sales go on, although they had to admit at one point that their robot simply “did not work“.

ZenRobotics revenue and balance

ZenRobotics revenue and balance

The firm will exist as long as investments flow, or how their website puts it:

zenroboticsslogan

Join us – we’ll be the last to go.

 

If there is money to be spent, it will be spent. Sometimes at all cost. More scrutiny on how it seeps away is warranted, especially when public money and pension funds are at stake.

/-Ed.

Conflict of interest: Timo Ahopelto has made malicious and obviously false statements about me at some occasions. May the reader decide, but I am digging into facts here.